Evolution into a Research and Development-Driven Company and Open Innovation

「The company will strengthen initiatives integrating “R2B” with monozukuri “P,” focusing on maximizing the business and monetization while improving the speed and scale of commercializing new products.」

「The company will accelerate the expansion of high-value-added products by increasing sales for ZEB applications, where walls and windows generate power, and strengthening perovskite R&D.」

「The company is expanding its catheter product lineup through open innovation, including the acquisition of a company with biodegradable magnesium stent technology and the import and sale of thrombectomy stents.」

「Research into the biodegradable biopolymer “Green Planet®” is progressing, including various processing technologies that are key to market development and formulation technologies to enhance the required functionality, strengthening our biomanufacturing capabilities. Joint development with major brand owners in Japan, the United States and Europe is also progressing smoothly.」

「The innovative project to produce Green Planet from CO2 and hydrogen, selected for NEDO’s Green Innovation Fund Project, has entered full-scale operation.」

「We will strengthen initiatives under “R&B＋P (Productions),” which strongly integrates R&B with manufacturing, and rapidly put new technologies into practical use in a competitive form. We established the “Monozukuri” R&B and Production Technology Collaboration Council and are accelerating these initiatives.」

「We will pursue the research and development of innovative technology to produce Green Planet from CO2 and hydrogen using hydrogen-oxidizing bacteria, with a view to the social implementation of the government’s priority policy on “biomanufacturing.”」

「In Pharma, contract manufacturing of COVID-19 vaccines at Kaneka Eurogentec is progressing smoothly in the biopharmaceuticals business. We will accelerate the implementation of joint research on biopharmaceutical production technologies with the Catholic University of Leuven in Belgium.」

「We will hone our own technologies and select and concentrate on creating seeds for the future. By combining cutting-edge technologies and business assets from around the world through open innovation and M&A, we will continue taking on challenges as an “experimental company.”」

「We are working to improve productivity and create new business value through the “selection and concentration” of R&B (Research & Business) and the promotion of DX, including in indirect functions, while also pursuing thorough cost rationalization, including expenses.」

「We view the COVID-19 pandemic as an opportunity for an internal paradigm shift and are working to improve productivity by selecting and concentrating R&B (Research & Business) activities and introducing a new work culture, including remote work.」

「With “R&B” (Research & Business), “globalization” and “human resources development” as our growth drivers, we will transform our business structure and accelerate growth for our Group by strengthening our initiatives as a solutions provider.」

「We have made R&B (Research & Business), globalization and human resources development our growth drivers, and will accelerate the strengthening of business approaches from the perspective of markets and customers, productivity improvements across the entire value chain linking research, manufacturing and sales, and globalization rooted in local perspectives.」

「With “R&D,” “globalization” and “human resources development” as our growth drivers, we will transform our business structure and accelerate growth for our Group by strengthening our initiatives as a solutions provider.」

「With “R&D,” “globalization” and “human resources development” as our growth drivers, we will transform our business structure and accelerate growth for our Group by strengthening our initiatives as a solutions provider.」

「With “R&D,” “globalization” and “human resources development” as our growth drivers, we will transform our business structure and accelerate growth for our Group by strengthening our initiatives as a solutions provider.」

「We will strengthen open innovation by utilizing the Kaneka US Innovation Center established on the U.S. West Coast the year before last.」

「With “R&D,” “globalization” and “human resources development” as our growth drivers, we will transform our business structure and accelerate growth for our Group by thoroughly pursuing initiatives as a solutions provider.」

「With “R&D,” “globalization” and “human resources development” as our growth drivers, we will actively pursue open innovation, strengthen the earnings power of our core businesses and accelerate the transformation of our business portfolio.」

「We will accelerate the transformation of our business portfolio by making research and development and the promotion of globalization our growth drivers. We will promote open innovation and seek to expand our businesses in both new and existing fields in the functional resins, electronics and life sciences domains.」